- Info
- Insider Trading
- Financials
- Holders: SRZN, SRZN
Surrozen, Inc./DE - Common Stock, $0.0001 par value per share (SRZN)
CUSIP: 86889P208
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 8,545,455
- Total 13F shares
- 4,529,305
- Share change
- +581,657
- Total reported value
- $40,492,894
- Price per share
- $8.94
- Number of holders
- 30
- Value change
- +$5,077,667
- Number of buys
- 11
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 86889P208?
CUSIP 86889P208 identifies SRZN - Surrozen, Inc./DE - Common Stock, $0.0001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 86889P208:
Top shareholders of SRZN - Surrozen, Inc./DE - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Column Group LLC |
13F
|
Company |
—
class O/S missing
|
1,499,773
|
$17,487,353 | — | 31 Mar 2025 | |
| 5AM Partners VII, LLC |
13D/G
|
— |
9.9%
|
908,387
|
$9,102,038 | $0 | 26 Mar 2025 | |
| Venrock Healthcare Capital Partners III, L.P. |
13D/G
|
— |
9.9%
|
872,546
|
$8,742,911 | $0 | 26 Mar 2025 | |
| AI Biotechnology LLC |
13D/G
|
— |
9.9%
|
844,563
|
$8,462,521 | $0 | 24 Mar 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
7.9%
|
679,130
|
$7,918,656 | — | 31 Mar 2025 | |
| VR Adviser, LLC |
13F
|
Company |
7.4%
|
632,931
|
$7,379,975 | — | 31 Mar 2025 | |
| Nantahala Capital Management, LLC |
13D/G
13F
|
Company |
5.2%
|
455,299
|
$4,011,184 | +$1,025,211 | 30 Jun 2025 | |
| 5AM Venture Management, LLC |
13F
|
Company |
3.6%
|
310,000
|
$3,614,600 | — | 31 Mar 2025 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
3.3%
|
285,782
|
$3,332,218 | — | 31 Mar 2025 | |
| Vivo Capital, LLC |
13F
|
Company |
3%
|
260,000
|
$3,031,600 | — | 31 Mar 2025 | |
| Samsara BioCapital, LLC |
13F
|
Company |
—
mixed-class rows
|
341,399
mixed-class rows
|
$2,817,724 | — | 31 Mar 2025 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
2.8%
|
240,826
|
$2,808,031 | — | 31 Mar 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
13D/G
|
Company |
0.79%
from 13D/G
|
204,934
|
$2,389,530 | — | 31 Mar 2025 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
2%
|
170,000
|
$1,982,200 | — | 31 Mar 2025 | |
| PERCEPTIVE ADVISORS LLC |
13D/G
13F
|
Company |
1.9%
|
166,666
|
$1,669,993 | $0 | 31 Mar 2025 | |
| Of The University Of California Regents |
13F
|
Individual |
—
mixed-class rows
|
216,540
mixed-class rows
|
$1,555,277 | — | 31 Mar 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1%
|
88,653
|
$1,033,694 | — | 31 Mar 2025 | |
| Euclidean Capital LLC |
13F
|
Company |
—
mixed-class rows
|
258,529
mixed-class rows
|
$1,027,660 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.8%
|
68,026
|
$793,183 | — | 31 Mar 2025 | |
| EcoR1 Capital, LLC |
13F
|
Company |
—
class O/S missing
|
66,665
|
$777,314 | — | 31 Mar 2025 | |
| Nantahala Capital Partners Limited Partnership |
13D/G
|
— |
2.2%
|
73,918
|
$740,658 | -$1,032,581 | 31 Mar 2025 | |
| Benny Soffer |
3/4/5
|
FORMER DIRECTOR |
—
mixed-class rows
|
2,029,667
mixed-class rows
|
$716,300 | — | 11 Aug 2021 | |
| Kevin Harold Livingston |
3/4/5
|
Former Chief Financial Officer |
—
mixed-class rows
|
2,029,667
mixed-class rows
|
$716,300 | — | 11 Aug 2021 | |
| Life Sciences Consonance |
3/4/5
|
Former 10% Holder |
—
mixed-class rows
|
2,029,667
mixed-class rows
|
$716,300 | — | 11 Aug 2021 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
—
mixed-class rows
|
163,456
mixed-class rows
|
$645,442 | — | 31 Mar 2025 | |
| Board of Trustees of The Leland Stanford Junior University |
13F
|
Company |
0.61%
|
52,130
|
$607,836 | — | 31 Mar 2025 | |
| Trustees of Columbia University in the City of New York |
13F
|
Company |
—
mixed-class rows
|
81,263
mixed-class rows
|
$559,864 | — | 31 Mar 2025 | |
| HEIGHTS CAPITAL MANAGEMENT, INC |
13F
|
Company |
0.53%
|
44,978
|
$524,443 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.41%
|
34,764
|
$405,348 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.3%
|
25,261
|
$294,609 | — | 31 Mar 2025 | |
| Alyeska Investment Group, L.P. |
13D/G
13F
|
Company |
0.8%
|
26,855
|
$269,087 | $0 | 31 Dec 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
—
mixed-class rows
|
63,381
mixed-class rows
|
$256,000 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.17%
|
14,226
|
$165,875 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.1%
|
8,320
|
$97,011 | — | 31 Mar 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
—
class O/S missing
|
833,333
|
$25,000 | — | 31 Mar 2025 | |
| LMR Partners LLP |
13F
|
Company |
—
class O/S missing
|
648,285
|
$19,449 | — | 31 Mar 2025 | |
| BRIDGER MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
466,666
|
$14,000 | — | 31 Mar 2025 | |
| Geertrui Vanhove |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
32,412
|
$12,317 | — | 15 Dec 2022 | |
| Christopher Haqq |
3/4/5
|
Former Director |
—
class O/S missing
|
30,000
|
$11,400 | — | 11 Aug 2021 | |
| Donald J. Santel |
3/4/5
|
Former Director |
—
class O/S missing
|
30,000
|
$11,400 | — | 11 Aug 2021 | |
| Jennifer Jarrett |
3/4/5
|
Former Director |
—
class O/S missing
|
30,000
|
$11,400 | — | 11 Aug 2021 | |
| Yeh Wen-Chen |
3/4/5
|
Chief Scientific Officer |
—
class O/S missing
|
27,216
|
$10,342 | — | 15 Jun 2023 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
—
class O/S missing
|
166,666
|
$5,000 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
402
|
$4,687 | — | 31 Mar 2025 | |
| WOLVERINE ASSET MANAGEMENT LLC |
13F
|
Company |
0%
|
281
|
$3,276 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
—
mixed-class rows
|
2,951
mixed-class rows
|
$2,380 | — | 31 Mar 2025 | |
| CANTOR FITZGERALD, L. P. |
13F
|
Individual |
—
class O/S missing
|
70,824
|
$2,125 | — | 31 Mar 2025 | |
| Boxer Capital Management, LLC |
13F
|
Company |
—
class O/S missing
|
66,666
|
$2,000 | — | 31 Mar 2025 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
24,614
|
$738 | — | 31 Mar 2025 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
—
class O/S missing
|
20,718
|
$622 | — | 31 Mar 2025 |
Institutional Holders of Surrozen, Inc./DE - Common Stock, $0.0001 par value per share (SRZN) as of Q2 2025
As of 30 Jun 2025,
Surrozen, Inc./DE - Common Stock, $0.0001 par value per share (SRZN) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,529,305 shares.
The largest 10 holders included
STEMPOINT CAPITAL LP, VR ADVISER, LLC, RA CAPITAL MANAGEMENT, L.P., 5AM Venture Management, LLC, Stonepine Capital Management, LLC, Vivo Capital, LLC, SAMSARA BIOCAPITAL, LLC, Nantahala Capital Management, LLC, VANGUARD GROUP INC, and ACUTA CAPITAL PARTNERS, LLC.
This page lists
30
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
29
Q2 2025 holders
30
Holder diff
1
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.